XML 125 R111.htm IDEA: XBRL DOCUMENT v3.19.1
Note 16 - Shareholders' Equity - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - € / shares
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Non-vested options granted (in shares) 165,000    
Employee Stock Option [Member]      
Outstanding - number (in shares) 1,207,600 1,427,438 917,188
Outstanding - Weighted average exercise price (in EUR per share) € 2.61 € 2.94 € 2.79
Non-vested options granted (in shares) 165,000 260,000 575,000
Granted - Weighted average exercise price (in EUR per share) € 2.65 € 2.39 € 3.22
Exercised - number (in shares) (60,000)
Exercised - Weighted average exercise price (in EUR per share) € 1.91
Forfeited - number (in shares) (25,000) (134,750) (64,750)
Forfeited - Weighted average exercise price (in EUR per share) € 3.05 € 3.09 € 3.30
Expired - number (in shares) (285,088)
Expired - Weighted average exercise price (in EUR per share) € 3.99
Outstanding - number (in shares) 1,347,600 1,207,600 1,427,438
Outstanding - Weighted average exercise price (in EUR per share) € 2.61 € 2.61 € 2.94
Exercisable - number (in shares) 772,600 598,850 774,938
Exercisable - Weighted average exercise price (in EUR per share) € 2.44 € 2.29 € 2.87
Share purchase options available for grant - number (in shares) 250,428 250,428 243,428